Intellectus Partners LLC Sells 483 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Intellectus Partners LLC cut its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 2.5% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 19,016 shares of the financial services provider’s stock after selling 483 shares during the quarter. Intellectus Partners LLC’s holdings in iShares Biotechnology ETF were worth $2,583,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. International Assets Investment Management LLC acquired a new stake in shares of iShares Biotechnology ETF in the 4th quarter valued at about $76,425,000. Itau Unibanco Holding S.A. acquired a new position in iShares Biotechnology ETF during the third quarter valued at approximately $48,242,000. Tower Research Capital LLC TRC grew its stake in shares of iShares Biotechnology ETF by 28,138.4% in the third quarter. Tower Research Capital LLC TRC now owns 98,552 shares of the financial services provider’s stock worth $12,052,000 after purchasing an additional 98,203 shares during the last quarter. Calamos Advisors LLC bought a new stake in iShares Biotechnology ETF during the fourth quarter valued at $7,648,000. Finally, Cumberland Advisors Inc. bought a new position in shares of iShares Biotechnology ETF during the 3rd quarter worth about $6,297,000. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Up 0.7 %

NASDAQ:IBB traded up $0.82 on Friday, hitting $126.49. The stock had a trading volume of 833,050 shares, compared to its average volume of 1,534,186. iShares Biotechnology ETF has a 1 year low of $111.83 and a 1 year high of $141.16. The firm’s fifty day simple moving average is $134.27 and its two-hundred day simple moving average is $129.74.

iShares Biotechnology ETF Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Stockholders of record on Friday, March 22nd were given a dividend of $0.126 per share. The ex-dividend date of this dividend was Thursday, March 21st. This represents a $0.50 dividend on an annualized basis and a dividend yield of 0.40%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.